Cargando…

Seroprevalence rates in children aged 3-6 years after implementing a two-dose varicella vaccination: A observational study

The study evaluates the outcomes of including varicella vaccines (VarV) in the local expanded programme on immunization (EPI) on the seropositivity rates and corresponding protective effects for children aged 3–6 years in Suzhou. The study is observational. Varicella prevalence in children was asses...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhuoyu, Zhang, Yunyan, Yu, Jiangtao, Dong, Chen, Zhang, Jun, Liu, Na, Qian, Chihua, Luan, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Licensed Vaccines
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294751/ https://www.ncbi.nlm.nih.gov/pubmed/37203320 http://dx.doi.org/10.1080/21645515.2023.2211465

Ejemplares similares

Seroprevalence comparison of different varicella vaccines among Turkish children
por: Choi, BongKyoo, et al.
Publicado: (2022)

Immunogenicity and safety of a live attenuated varicella vaccine co-administered with inactive hepatitis A vaccine: A phase 4, single-center, randomized, controlled trial
por: Sun, Dapeng, et al.
Publicado: (2023)

Cross-reactive humoral immunity of clade 2 Oka and MAV/06 strain-based varicella vaccines against different clades of varicella–zoster virus
por: Hwang, Ji-Young, et al.
Publicado: (2023)

Mumps-specific antibody persistence in children aged 3–7 years immunized with two doses of mumps-containing vaccines: A prospective cohort study in Jiangsu Province, China
por: Sun, Jinfang, et al.
Publicado: (2023)

Improving Tdap maternal immunization rate in Saudi Arabia
por: Aldoosari, Agariad, et al.
Publicado: (2023)

Response to a letter to the editor regarding ‘ the comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka’
por: Sahbudak Bal, Zumrut, et al.
Publicado: (2022)

Trends in research related to vaccine and cancer prevention from 1992 to 2022: A 30-years bibliometric analysis
por: Zhang, Luofei, et al.
Publicado: (2023)

Effectiveness of varicella vaccination during an outbreak in a large one-dose-vaccinated population in Shanghai
por: Lin, Mingzhu, et al.
Publicado: (2022)

Measles vaccine uptake and COVID-19
por: Daungsupawong, Hinpetch, et al.
Publicado: (2023)

Estimation of single-dose varicella vaccine effectiveness in South Korea using mathematical modeling
por: Suh, Jiyeon, et al.
Publicado: (2022)

ASVAC2022 : 8(th) Asian Vaccine Conference
por: Galagoda, Geethani C. S., et al.
Publicado: (2023)

Public health impact of herpes zoster vaccination on older adults in Hong Kong
por: Chan, Paul K. S., et al.
Publicado: (2023)

Measles vaccine uptake among Italian medical students compared to the pre-COVID-19 era
por: Ferrari, Cristiana, et al.
Publicado: (2023)

Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases
por: Van den Steen, Peter, et al.
Publicado: (2023)

An open-label, non-randomized study investigating the safety and efficacy of smallpox vaccine, LC16, as post-exposure prophylaxis for mpox
por: Tomita, Noriko, et al.
Publicado: (2023)

Penta- and hexavalent vaccination of extremely and very-to-moderate preterm infants born at less than 34 weeks and/or under 1500 g: A systematic literature review
por: Knuf, Markus, et al.
Publicado: (2023)

Reduced reactogenicity of primary vaccination with DT3aP-HBV-IPV/Hib compared with DT2aP-HBV-IPV-Hib among infants: Mathematical projections in six countries
por: George, Marina, et al.
Publicado: (2023)

Comparison of varicella outbreaks in schools in China during different vaccination periods
por: Sun, Xiang, et al.
Publicado: (2022)

Cost effectiveness and budget impact of universal varicella vaccination in Russia
por: Marijam, Alen, et al.
Publicado: (2022)

Evaluation of the seroprevalence of measles, rubella, mumps, and varicella and the requirement for additional vaccination based on the JSIPC guidelines among emergency medical technicians at eight fire stations in Narita, Japan: a project review
por: Hase, Ryota, et al.
Publicado: (2021)

Safety and immunogenicity of single dose live attenuated varicella vaccine (VR 795 Oka strain) in healthy Indian children: A randomized controlled study
por: Mitra, Monjori, et al.
Publicado: (2015)

Waning rate of immunity and duration of protective immunity against diphtheria toxoid as a function of age and number of doses: Systematic review and quantitative data analysis
por: Kitamura, Noriko, et al.
Publicado: (2022)

The health and economic impact of switching vaccines in universal varicella vaccination programs using a dynamic transmission model: An Israel case study
por: Kujawski, Stephanie A., et al.
Publicado: (2022)

Evaluating the impact of universal varicella vaccination among preschool-aged children in Qingdao, China: An interrupted time-series analysis
por: Gao, Zheng, et al.
Publicado: (2022)

A randomized trial assessing the efficacy, immunogenicity, and safety of vaccination with live attenuated varicella zoster virus-containing vaccines: ten-year follow-up in Russian children
por: Namazova-Baranova, Leyla, et al.
Publicado: (2021)

Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China
por: Li, Dong, et al.
Publicado: (2022)

Measles seroprevalence in persons over one year of age in Chandigarh, India
por: Mathew, Joseph L., et al.
Publicado: (2022)

Re-thinking yellow fever vaccines: fighting old foes with new generation vaccines
por: Montalvo Zurbia-Flores, Gerardo, et al.
Publicado: (2021)

Vaccination in preterm and low birth weight infants in India
por: Soans, Santosh, et al.
Publicado: (2021)

Letter to the editor: Correspondence on Chinese medical personnel vaccinations
por: Sekhar, Sejal C., et al.
Publicado: (2022)

Available evidence and potential for vaccines for reduction in antibiotic prescriptions
por: Gabutti, Giovanni
Publicado: (2022)

Maternal vaccines: ten considerations for vaccine introduction and scale-up in low- and middle-income countries from the maternal, newborn, child, and adolescent health perspective
por: Khan, Sadaf, et al.
Publicado: (2021)

Advances in the progress of monoclonal antibodies for rabies
por: Fan, Linlin, et al.
Publicado: (2022)

Burden of vaccine-preventable diseases among at-risk adult populations in the US
por: Kolobova, Irina, et al.
Publicado: (2022)

Letter to the editor: Safety and immunogenicity of a novel recombinant rabies vaccine
por: Agarwal, Anurag, et al.
Publicado: (2022)

Gaps in knowledge about the vaccine coverage of immunocompromised children: a scoping review
por: MacDonald, Shannon E., et al.
Publicado: (2021)

The world’s largest measles-Rubella vaccination campaign in Pakistan: Time to invest in routine immunization
por: Rana, Muhammad Suleman, et al.
Publicado: (2022)

Assessment of mumps-containing vaccine effectiveness by dose during 2006 to 2020 in Quzhou, China
por: Yin, Zhiying, et al.
Publicado: (2022)

The progress of postapproval clinical studies on Sabin IPV
por: Shi, Li, et al.
Publicado: (2021)

Commentary on the implications of safety and efficacy studies in pediatric patients with administration of human rabies immune globulin (HRIG)?
por: Siegel, Jerry, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_04irepjup9835tiopcnoctf9bg